Correspondence 0001193125-23-171172 from ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858) (ACHV)
ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)
Date: June 21, 2023 · CIK: 0000949858 · Accession: 0001193125-23-171172
AI Filing Summary & Sentiment
File numbers found in text: 333-272641
Show Raw Text
CORRESP 1 filename1.htm CORRESP ACHIEVE LIFE SCIENCES, INC. 22722 29th Drive SE, Suite 100 Bothell, WA 98021 June 21, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Arzhang Navai Re: Achieve Life Sciences, Inc. Registration Statement on Form S-3 (File No. 333-272641) Requested Date: June 23, 2023 Requested Time: 4:00 PM Eastern Time Ladies and Gentlemen: Achieve Life Sciences (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Amanda L. Rose and Chelsea Anderson, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Anderson at (206) 389-4516 or, in her absence, to Ms. Rose at (206) 389-4553. * * * Sincerely, ACHIEVE LIFE SCIENCES, INC. By: /s/ John Bencich John Bencich Chief Executive Officer cc: Amanda L. Rose, Esq. Chelsea Anderson, Esq. Fenwick & West LLP [Signature Page to Company Acceleration Request Letter]